ONE PLATFORM. ALL POSSIBILITIES.
We are committed to revolutionizing transfection technologies, making them tailored, accessible, and affordable
OUR MISSION
Pioneering the Future of Genetic Medicine
Vectorialis is revolutionizing nucleic acid therapeutics from lab to clinic, targeting genetic disorders, infectious diseases, and cancer
Our VibroFect technology democratizes genetic medicine, empowering researchers worldwide to break barriers and accelerate breakthroughs
We’re transforming patient care through genetic medicine’s full potential
Ready to accelerate your genetic medicine research? Experience VibroFect today!
OUR HISTORY
A Revolution Inspired by Innovation and Opportunity
Years of relentless research and innovation. One transformative breakthrough: VibroFect
Every great innovation begins with a challenge. We experienced firsthand what every researcher knows: nucleic acid delivery needed a revolution. Low efficiency, unpredictable results, and toxicity concerns weren't just obstacles; they were opportunities to pioneer something extraordinary
That vision drove us to create VibroFect. Our patented platform combines mechanical stimulation with precision-engineered reagents to generate highly effective nanoparticles, transforming nucleic acid delivery from a source of frustration into a success. We’ve turned decades-old limitations into groundbreaking solutions
Today, VibroFect empowers researchers worldwide with superior transfection efficiency, unprecedented reliability, and the confidence to advance genetic medicine.
From challenge to breakthrough, from vision to reality. Experience the VibroFect revolution now!
OUR TEAM
-
Nina BONO
Ph.D.
Co-founder
MANAGING DIRECTOR
-
Gabriele CANDIANI
Ph.D.
Co-founder
PRESIDENT
-
Paul CHIPPERTON
MBA
Co-founder
Business & Strategy, BOD Chair
CUSTOMER & USER REVIEWS
Postdocs
Hellen (ViRNA user): “My efficiency rates went from 26% to 73%.”
John (ViALL user): “I’ve tried every transfection method out there. VibroFect is the only one that works reliably across different cell lines.”
Ph.D. students
Sophia (ViALL & ViRNA user): “VibroFect saved my thesis. Consistent results every single time with no more failed experiments.”
Sarah (ViALL user): “Consistent as my coffee addiction!”
Lab manager
Paul (ViALL user): “Reproducible, reliable, totally viable!” & “Training new students is so much easier now. VibroFect just works: no steep learning curve.”
Sr. scientits & professors
Stephy (ViRNA customer): “Primary neurons? No problem. Stem cells? Easy. VibroFect handles what others can't.”
Loredan (ViALL customer): “VibroFect data is publication-ready every time. Reviewers love the consistency.”
Elena (ViPRO customer): “The system paid for itself in two months by eliminating costly experimental failures.”
NEWS
-
![]()
CRS 2025 Annual meeting and Exposition
Controlled Release Society 2025 congress
Philadelphia, USA
-
![]()
CRS 2024 Annual meeting and Exposition
Controlled Release Society 2024 congress
Bologna, Italy
-
![]()
ETPN 2024 congress
European Technology Platform on Nanomedicine 2024 congress
Milan, Italy
-
![]()
Premio 2031: Fondazione Toscana Life Sciences
Siena, Italy
-
![]()
Switch 2 Product: PoliHUB innovation challenge
Milan, Italy
-
![]()
Janssen Grant
-
![]()
ITALIAN TECH WEEK
2023
Turin, Italy
-
![]()
Startcup Lombardia
Startup competition
Milan, Italy
